Overview Adult Attention Deficit Hyperactivity Disorder Status: Completed Trial end date: 2013-12-01 Target enrollment: Participant gender: Summary A Phase 2 study of SEP-225289 in adults with attention deficit hyperactivity disorder (ADHD). Phase: Phase 2 Details Lead Sponsor: Sunovion